First Time Loading...

Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF

Watchlist Manager
Swedish Orphan Biovitrum AB (publ) Logo
Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF
Watchlist
Price: 22.87 USD Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one BIOVF stock under the Base Case scenario is 30.5 USD. Compared to the current market price of 22.87 USD, Swedish Orphan Biovitrum AB (publ) is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOVF Relative Value
Base Case
30.5 USD
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.3
P/S
P/S
Price to Sales
4.3
vs History
14
vs Industry
68
Median 3Y
3.8
Median 5Y
3.8
Industry
8.1
Forward
3.9
More Details
39.6
P/E
P/E
Price to Earnings
39.6
vs History
1
vs Industry
4
Median 3Y
24.5
Median 5Y
20.8
Industry
26.2
Forward
26
More Details
21.3
P/OCF
P/OCF
Price to OCF
21.3
vs History
6
vs Industry
8
Median 3Y
14.6
Median 5Y
13.5
Industry
22.6
More Details
9.7
P/FCFE
P/FCFE
Price to FCFE
9.7
vs History
39
vs Industry
9
Median 3Y
76.6
Median 5Y
7.9
Industry
21.3
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
36
vs Industry
34
Median 3Y
2.6
Median 5Y
2.7
Industry
2.5
More Details
4.8
EV/S
EV/S
Enterprise Value to Sales
4.8
vs History
19
vs Industry
55
Median 3Y
4.2
Median 5Y
4.3
Industry
7.3
Forward
4.3
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
19
vs Industry
52
Median 3Y
5.5
Median 5Y
5.7
Industry
9.1
More Details
13.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.4
vs History
6
vs Industry
8
Median 3Y
12
Median 5Y
11.6
Industry
4.4
Forward
11.6
More Details
22.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.6
vs History
1
vs Industry
6
Median 3Y
18
Median 5Y
16.6
Industry
4.3
Forward
18.7
More Details
23.7
EV/OCF
EV/OCF
Enterprise Value to OCF
23.7
vs History
6
vs Industry
7
Median 3Y
16.4
Median 5Y
16.4
Industry
5.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
1
Median 3Y
23.7
Median 5Y
19.1
Industry
3.2
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
47
vs Industry
55
Median 3Y
1.4
Median 5Y
1.5
Industry
5
More Details

Multiples Across Competitors

BIOVF Competitors Multiples
Swedish Orphan Biovitrum AB (publ) Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Swedish Orphan Biovitrum AB (publ)
OTC:BIOVF
95.1B USD 4.3 39.6 13.4 22.6
US
Abbvie Inc
NYSE:ABBV
284B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
149.1B USD 5.3 22.2 16.5 24.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.1B USD 10.4 28.5 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
102.6B USD 7.8 25.9 17.4 19.1
AU
CSL Ltd
ASX:CSL
133B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
81.4B USD 3 168.2 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
48B USD 7 -10.2 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.1B USD 3.2 26.6 13.7 17.1
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
BIOVF intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOVF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOVF stock valuation using valuation multiples.
Wall Street Estimates
BIOVF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOVF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.